The Views of 1,500 Patient Groups on the Pharmaceutical Industry and ESG (Environmental, Social, and Governance) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Pharma and ESG – The Patient Perspective – The Views of 1,500 Patient Groups” report has been added to This analysis of patient-group opinions on ESG is based on two online Patient-group familiarity with ESG…
Read More